Skip to main content
Year archive

STADA Arzneimittel AG — 2011 filings

All 48 regulatory filings released by STADA Arzneimittel AG (SAZ) in 2011, sourced directly from the official regulator.

48 Filings
2011 Period
2011 filings (48)
Filing Released Lang
STADA: Purchase of a branded product portfolio in Eastern Europe as well as in the Middle East successfully concluded - Central Europe still open
Regulatory Filings
2011-12-30 English
STADA subsidiary increases commitment to charity
Environmental & Social Information
2011-12-05 English
STADA strengthens long-term refinancing with successful securing of promissory notes in the amount of EUR 400 million
Capital/Financing Update
2011-12-01 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-11-24 English
Release according to Article 26a, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-11-23 English
STADA sales companies very successful in large-volume 7th AOK tender in the German generics market
Earnings Release Q3 2011
2011-11-23 English
Q3 Report 2011
Interim / Quarterly Report 9M 2011
2011-11-11 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-11-10 English
STADA: Stabilization of business outlook in Serbia after letter of comfort from Serbian government
Legal Proceedings Report
2011-11-10 English
STADA: STADA 1-9/2011: Good development of sales and operating earnings - High burden on reported key earnings figures through one-time special effects - Confirmation of long-term growth targets
Earnings Release 9M 2011
2011-11-10 English
STADA: STADA signs contract on the purchase of a generics business in Switzerland
M&A Activity
2011-11-09 English
STADA: STADA sales companies very successful in tenders for discount agreements with various German public health insurance organizations
Regulatory Filings
2011-10-31 English
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing
2011-10-06 German
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing
2011-09-23 German
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing
2011-09-23 German
STADA: Increased risk of default on outstanding receivables from Serbian pharmaceutical wholesalers leads to burdening one-time special effects of approx. EUR 97 million before taxes
Regulatory Filings
2011-09-21 English
STADA Arzneimittel AG: STADA and Richter cooperate for development of two biosimilar products for two monoclonal antibodies: Rituximab and Trastuzumab
Regulatory Filings
2011-08-30 English
Q2 Report 2011
Interim / Quarterly Report H1 2011
2011-08-16 English
STADA: Positive business development in H1/2011 - Increase of Group sales and all key earnings figures - Outlook remains positive for 2011/2012
Earnings Release H1 2011
2011-08-11 English
STADA: STADA sales companies achieve very good results in fourth DAK tender in the German generics market
Regulatory Filings
2011-08-01 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-07-29 English
STADA: STADA and Grunenthal sign contracts on the purchase of a branded product portfolio in Central and Eastern Europe as well as the Middle East
M&A Activity
2011-07-22 English
Datum:05.07.2011
AGM Information
2011-07-05 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-06-30 English
STADA AGM 2011: Executive Board continues to expect further growth in Group sales and earnings in 2011 and 2012
AGM Information
2011-06-16 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-05-26 German
STADA acquires British branded product Cetraben(R) for GBP 30 million (approx. EUR 34.6 million)
M&A Activity
2011-05-26 English
STADA negotiating the purchase of a generics business in Switzerland
M&A Activity
2011-05-19 English
Datum:13.05.2011
Annual Report FY 2010
2011-05-13 German
Q1 Report 2011
Interim / Quarterly Report Q1 2011
2011-05-13 English
STADA and Grunenthal in exclusive negotiations on the purchase of a branded product portfolio in Central and Eastern Europe as well as the Middle East for approx. EUR 360 million
M&A Activity
2011-05-12 English
STADA: Positive business development in Q1/2011 - Increase of Group sales and all key earnings figures - Outlook remains positive for 2011/2012
Earnings Release Q1 2011
2011-05-12 English
STADA Group achieves strong result in 6th AOK tender in the German generics market
Regulatory Filings
2011-05-11 English
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 16.06.2011 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2011-05-06 German
Datum:04.05.2011
Annual Report FY 2010
2011-05-04 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-04-28 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-03-31 English
Annual Report 2010
Annual Report FY 2010
2011-03-31 English
Annual Report 2010
Annual Report FY 2010
2011-03-31 German
STADA: Good operating results confirm successful financial year 2010 - positive outlook for 2011/2012
Earnings Release FY 2010
2011-03-30 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-03-28 German
Report Publication Announcement 2011
Report Publication Announcement
2011-02-28 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2011-02-28 English
STADA Arzneimittel AG: 2010 preliminary results confirm operationally successful year - dividend to amount to EUR 0.37 with unchanged distribution ratio - positive outlook for 2011/2012
Earnings Release FY 2010
2011-02-28 English
Hinweis auf Quartalsfinanzbericht
Report Publication Announcement
2011-02-28 German
Datum:28.02.2011
Report Publication Announcement
2011-02-28 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-02-03 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-01-14 English